Statera Biopharma, Inc. Common Stock
STAB
STAB was delisted on the 11th of January, 2023.
22 hedge funds and large institutions have $764K invested in Statera Biopharma, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.
8% less funds holding
Funds holding: 24 → 22 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
30% less capital invested
Capital invested by funds: $1.09M → $764K (-$323K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
+$446K |
| 2 |
Renaissance Technologies
New York
|
+$198K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$76K |
| 4 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$61.5K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$50.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$164K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$108K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$37K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$20K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$12K |
STAB Hedge Fund Activity: Q1 2015 in Review
22 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q1 2015, worth a combined $764K — down 30% from $1.09M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of STAB and 5 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was California Public Employees Retirement System, adding an estimated $446K. The largest seller was Anson Funds Management, exiting entirely with an estimated $164K sold.
- 22 institutional investors held Statera Biopharma, Inc. Common Stock (STAB) as of Q1 2015, down from 24 in Q4 2014.
- Funds reported $764K of Statera Biopharma, Inc. Common Stock stock for Q1 2015, down 30% quarter-over-quarter.
- 5 funds opened new Statera Biopharma, Inc. Common Stock positions in Q1 2015 and 7 closed out, a net change of -2 holders.
- The largest Statera Biopharma, Inc. Common Stock buyer in Q1 2015 was California Public Employees Retirement System, an estimated $446K added.
- The largest Statera Biopharma, Inc. Common Stock seller in Q1 2015 was Anson Funds Management, an estimated $164K sold.
Based on aggregated 13F filings for Q1 2015.